Autism Treatment Market – By Type (Asperger Syndrome, Pervasive Developmental Disorder, Autistic Disorder and Disintegrative Disorder), By Application (Behavioral Approaches, Early Intervention, Medication, Dietary Approach and Others) And By Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America) Industry Analysis, Opportunity and Forecast 2020 To 2027
Published Date: Aug 2020
No. of Pages: 180
Status: Published
Report Code: ARI100901
Summary
Autism Spectrum Disorder Treatment Market was valued at USD 3.3 Billion by 2019, and is anticipated to grow at a CAGR of 4.6% during the forecast period 2020-2025.
Autism, also called autism spectrum disorder, is a complicated condition that contains problems with communication and behaviour. It can involve a wide range of symptoms and skills. ASD can be a minor problem or a disability that needs full-time care in a special facility. People with autism have trouble with communication. They have trouble understanding what other people think and feel. This makes it hard for them to express themselves, either with words or through gestures, facial expressions, and touch. ASD is found in individuals around the world, regardless of race, culture, or economic background. According to the Centers for Disease Control and Prevention Trusted Source, autism does occur more often in boys than in girls, with a 4 to 1 male-to-female ratio.
Key manufacturing vendors operating in the market Bristol-Myers Squibb, Otsuka Holdings Co.Ltd., Novartis AG, Roche Pharmaceuticals, Janssen Pharmaceuticals, Pfizer Inc., Actavis Inc., Autism Therapeutics, Teva Pharmaceuticals, Q BioMed Inc. and others.
Analyst Commentary
The Autism Spectrum Disorder (ASD) Treatment market is poised to receive upswing owing to increasing in Government funding and focus on autism specific programs government keeps a path toward new autism discoveries and support. Autism appropriations to ensure federal agencies that run programs for autism research, services and supports are appropriately funded by the government in order to provide better facility. Moreover, owing to higher cost the burden on family affected by autism is enormous. This extraordinary cost such ad further worsen the burden. The time and effort involved in coordinating the care and treatment plan across large no of providers has reduced the ability of many families to earn. The lack of verbal and nonverbal communications can be eliminated by assistive technologies utilizing Artificial Intelligence (AI), Machine Learning, and Deep Learning to recognize emergency circumstances and accordingly protect patients from physical and mental harms.
Segmentation
Global autism treatment market has been bifurcated on the basis of type, application and region. On the basis of type it is segmented as Asperger Syndrome, Pervasive Developmental Disorder, Autistic Disorder and Disintegrative Disorder. While significant developments have been made in a number of educational, psychosocial, and biological approaches, there is a lack of understanding of the comparative and cumulative effectiveness of the different treatment modalities. On the basis of application, it is segmented as Behavioral Approaches, Early Intervention, Medication, Dietary Approach and Others
Behavioral Approach accounted for major share in 2019 and is also the fastest growing segment prevalence of Autism with CAGR of 5.9% during the forecast period 2020-2025. Factors such as rising incidence and Spectrum Disorder (ASD), increasing government funding, sponsored awareness program regarding the behavioral approach are driving the segmental growth of Autism Spectrum Disorder (ASD) Treatment market during the forecast period 2020-2025
Regional Analysis
The Global Autism treatment market is divided into four major regions that are North America, Europe, Asia Pacific, South America and MEA. North America is the major region dominating the Autism Spectrum Disorder (ASD) Treatment Market with revenue share of 55.87% in 2019 and is also set to be fastest growing during the forecast period of 2020-2025. Furthermore, U.S. in North America region is dominating the Autism Spectrum Disorder (ASD) Treatment Market. This is owing to presence of major market players, availability of advanced medical facility and technological advancement in terms of screening process.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Component
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Autism Treatment Market
Chapter 5. Global Autism Treatment Market Overview, By Type, 2015 - 2027(USD Million)
5.1. Global Autism Treatment Market Share, By Type, 2015 - 2027 (USD Million)
5.1.1. Asperger Syndrome
5.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. Pervasive Developmental Disorder
5.1.2.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.3. Autistic Disorder
5.1.3.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.4. Disintegrative Disorder
5.1.4.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Global Autism Treatment Market Overview, By Application, 2015 - 2027(USD Million)
6.1. Global Autism Treatment Market Share, By Application, 2015 - 2027 (USD Million)
6.1.1. Behavioral Approaches
6.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. Early Intervention
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.3. Medication
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.4. Dietary Approach
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.5. Others
6.1.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.5.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 7. Global Autism Treatment Market Overview, By Geography, 2015 - 2027(USD Million)
7.1. Global Autism Treatment Market Share, By Geography, 2015 - 2027(USD Million)
7.1.1. Market Size and projections, by Countries, 2015 - 2027 (USD Million)
7.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 8. North America Autism Treatment Market Overview, By Countries, 2015 - 2027(USD Million)
8.1. North America Autism Treatment Market Overview, 2015 - 2027 (USD Million)
8.1.1. Market Size and projections, 2015 - 2027 (USD Million)
8.1.2. North America Autism Treatment Market Overview, By Type, 2015 - 2027 (USD Million)
8.1.3. North America Autism Treatment Market Overview, By Application, 2015 - 2027 (USD Million)
8.1.4. North America Autism Treatment Market Overview, By Countries, 2015 - 2027 (USD Million)
8.1.4.1. U.S. Autism Treatment Market Overview, 2015 - 2027 (USD Million)
8.1.4.1.1. Market Size and projections, 2015 - 2027 (USD Million)
8.1.4.1.2. U.S. Autism Treatment Market Overview, By Type, 2015 - 2027 (USD Million)
8.1.4.1.3. U.S. Autism Treatment Market Overview, By Application, 2015 - 2027 (USD Million)
8.1.4.2. Canada Autism Treatment Market Overview, 2015 - 2027 (USD Million)
8.1.4.2.1. Market Size and projections, 2015 - 2027 (USD Million)
8.1.4.2.2. Canada Autism Treatment Market Overview, By Type, 2015 - 2027 (USD Million)
8.1.4.2.3. Canada Autism Treatment Market Overview, By Application, 2015 - 2027 (USD Million)
8.1.4.3. Mexico Autism Treatment Market Overview, 2015 - 2027 (USD Million)
8.1.4.3.1. Market Size and projections, 2015 - 2027 (USD Million)
8.1.4.3.2. Mexico Autism Treatment Market Overview, By Type, 2015 - 2027 (USD Million)
8.1.4.3.3. Mexico Autism Treatment Market Overview, By Application, 2015 - 2027 (USD Million)
Chapter 9. Europe Autism Treatment Market Overview, By Countries, 2015 - 2027(USD Million)
9.1. Europe Autism Treatment Market Overview, 2015 - 2027 (USD Million)
9.1.1. Market Size and projections, 2015 - 2027 (USD Million)
9.1.2. Europe Autism Treatment Market Overview, By Type, 2015 - 2027 (USD Million)
9.1.3. Europe Autism Treatment Market Overview, By Application, 2015 - 2027 (USD Million)
9.1.4. Europe Skin Care Sizes Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.4.1. Germany
9.1.4.1.1. Market Size and projections, 2015 - 2027 (USD Million)
9.1.4.1.2. Germany Autism Treatment Market Overview, By Type, 2015 - 2027(USD Million)
9.1.4.1.3. Germany Autism Treatment Market Overview, By Application, 2015 - 2027(USD Million)
9.1.4.2. France
9.1.4.2.1. Market Size and projections, 2015 - 2027 (USD Million)
9.1.4.2.2. France Autism Treatment Market Overview, By Type, 2015 - 2027(USD Million)
9.1.4.2.3. France Autism Treatment Market Overview, By Application, 2015 - 2027(USD Million)
9.1.4.3. UK
9.1.4.3.1. Market Size and projections, 2015 - 2027 (USD Million)
9.1.4.3.2. UK Autism Treatment Market Overview, By Type, 2015 - 2027(USD Million)
9.1.4.3.3. UK Autism Treatment Market Overview, By Application, 2015 - 2027(USD Million)
9.1.4.4. Italy
9.1.4.4.1. Market Size and projections, 2015 - 2027 (USD Million)
9.1.4.4.2. Italy Autism Treatment Market Overview, By Type, 2015 - 2027(USD Million)
9.1.4.4.3. Italy Autism Treatment Market Overview, By Application 2015 - 2027(USD Million)
9.1.4.5. Spain
9.1.4.5.1. Market Size and projections, 2015 - 2027 (USD Million)
9.1.4.5.2. Spain Autism Treatment Market Overview, By Type, 2015 - 2027(USD Million)
9.1.4.5.3. Spain Autism Treatment Market Overview, By Application, 2015 - 2027(USD Million)
9.1.4.6. Rest of Europe
9.1.4.6.1. Market Size and projections, 2015 – 2027
9.1.4.6.2. Rest of Europe Autism Treatment Market Overview, By Type, 2015 - 2027(USD Million)
9.1.4.6.3. Rest of Europe Autism Treatment Market Overview, By Application, 2015 - 2027(USD Million)
Chapter 10. Asia Pacific Autism Treatment Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1. Asia Pacific Autism Treatment Market Overview, 2015 - 2027 (USD Million)
10.1.1. Market Size and projections, 2015 - 2027 (USD Million)
10.1.2. Asia Pacific Autism Treatment Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.3. Asia Pacific Autism Treatment Market Overview, By Application, 2015 - 2027 (USD Million)
10.1.4. Asia Pacific Autism Treatment Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.4.1. India
10.1.4.1.1. Market Size and projections, 2015 - 2027 (USD Million)
10.1.4.1.2. India Autism Treatment Market Overview, By Type, 2015 - 2027(USD Million)
10.1.4.1.3. India Autism Treatment Market Overview, By Application, 2015 - 2027 (USD Million)
10.1.4.2. China
10.1.4.2.1. Market Size and projections, 2015 - 2027(USD Million)
10.1.4.2.2. China Autism Treatment Market Overview, By Type, 2015 - 2027(USD Million)
10.1.4.2.3. China Autism Treatment Market Overview, By Application, 2015 - 2027 (USD Million)
10.1.4.3. Japan
10.1.4.3.1. Market Size and projections, 2015 - 2027 (USD Million)
10.1.4.3.2. Japan Autism Treatment Market Overview, By Type, 2015 - 2027(USD Million)
10.1.4.3.3. Japan Autism Treatment Market Overview, By Application, 2015 - 2027(USD Million)
10.1.4.4. South Korea
10.1.4.4.1. Market Size and projections, 2015 - 2027(USD Million)
10.1.4.4.2. South Korea Autism Treatment Market Overview, By Type, 2015 - 2027(USD Million)
10.1.4.4.3. South Korea Autism Treatment Market Overview, By Application, 2015 - 2027 (USD Million)
10.1.4.5. Rest of Asia Pacific
10.1.4.5.1. Market Size and projections, 2015 - 2027 (USD Million)
10.1.4.5.2. Rest of Asia Pacific Autism Treatment Market Overview, By Type, 2015 - 2027(USD Million)
10.1.4.5.3. Rest of Asia Pacific Autism Treatment Market Overview, By Application, 2015 - 2027 (USD Million)
Chapter 11. Middle East & Africa Autism Treatment Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1. Middle East & Africa Autism Treatment Market Overview, 2015 - 2027 (USD Million)
11.1.1. Market Size and projections, 2015 - 2027 (USD Million)
11.1.2. Middle East & Africa Autism Treatment Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.3. Middle East & Africa Autism Treatment Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.4. Middle East & Africa Autism Treatment Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1.4.1. GCC
11.1.4.1.1. Market Size and projections, 2015 - 2027 (USD Million)
11.1.4.1.2. GCC Autism Treatment Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.1.3. GCC Autism Treatment Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.4.2. South Africa
11.1.4.2.1. Market Size and projections, 2015 - 2027 (USD Million)
11.1.4.2.2. South Africa Autism Treatment Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.2.3. South Africa Autism Treatment Market Overview, By Application, 2015 - 2027 (USD Million)
11.1.4.3. Rest of Middle East & Africa
11.1.4.3.1. Market Size and projections, 2015 - 2027 (USD Million)
11.1.4.3.2. Rest of Middle East & Africa Autism Treatment Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4.3.3. Rest of Middle East & Africa Autism Treatment Market Overview, By Application, 2015 - 2027 (USD Million)
Chapter 12. South America Autism Treatment Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1. South America Autism Treatment Market Overview, 2015 - 2027 (USD Million)
12.1.1. Market Size and projections, 2015 - 2027 (USD Million)
12.1.2. South America Autism Treatment Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.3. South America Autism Treatment Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.4. South America Autism Treatment Market Overview, By Countries, 2015- 2026 (USD Million)
12.1.5. Brazil
12.1.5.1. Market Size and projections, 2015 - 2027 (USD Million)
12.1.5.2. Brazil Autism Treatment Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.5.3. Brazil Autism Treatment Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.6. Argentina
12.1.6.1. Market Size and projections, 2015 - 2027 (USD Million)
12.1.6.2. Argentina Autism Treatment Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.6.3. Argentina Autism Treatment Market Overview, By Application, 2015 - 2027 (USD Million)
12.1.7. Rest of South America
12.1.7.1. Market Size and projections, 2015 – 2027
12.1.7.2. Rest of South America Autism Treatment Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.7.3. Rest of South America Autism Treatment Market Overview, By Application, 2015 - 2027 (USD Million)
Chapter 13. Competitive Landscape
13.1. Competitive environment, 2021
13.2. Strategic framework
13.2.1. Partnership/agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New Size development
Chapter 14. Key Vendor Analysis
14.1. Bristol Myers Squibb
14.1.1. Company overview
14.1.2. Financial perTypeance
14.1.3. Product Benchmarking
14.1.4. Recent initiatives
14.1.5. SWOT analysis
14.2. Otsuka Holdings Co.Ltd.
14.2.1. Company overview
14.2.2. Financial perTypeance
14.2.3. Product Benchmarking
14.2.4. Recent initiatives
14.2.5. SWOT analysis
14.3. Novartis AG
14.3.1. Company overview
14.3.2. Financial perTypeance
14.3.3. Product Benchmarking
14.3.4. Recent initiatives
14.4. Roche Pharmaceuticals
14.5. Janssen Pharmaceuticals
14.6. Pfizer Inc.
14.7. Actavis Inc.
14.8. Autism Therapeutics
14.9. Teva Pharmaceuticals
14.10. Q BioMed Inc.
14.11. others
Chapter 15. Autism Treatment Market Cost Analysis
15.1. Autism Treatment Market Key Size Analysis
15.1.1. Key Size
15.1.2. Price Trend of Key Size
15.1.3. Key Suppliers of Size
15.1.4. Market Concentration Rate of Size
15.1.5. Labor Cost
Chapter 16. Sourcing Strategy and Downstream Buyers
16.1. Autism Treatment Market Chain Analysis
16.2. Upstream Size Sourcing
16.3. Autism Treatment Market Major Manufacturers in 2021
16.4. Downstream Buyers
Chapter 17. Marketing Strategy Analysis, Distributors/Traders
17.1. Marketing Channel
17.1.1. Direct Marketing
17.1.2. Indirect Marketing
17.1.3. Marketing Channel Development Trend
17.2. Market Positioning
17.2.1. Pricing Strategy
17.2.2. Brand Strategy
17.2.3. Target Client
17.3. Distributors/Traders List
Chapter 18. Market Effect Factors Analysis
18.1. Technology Progress/Risk
18.1.1. Substitutes Threat
18.1.2. Technology Progress in Related Size
18.2. Consumer Needs/Customer Preference Change
18.3. Economic/Political Environmental Change
Chapter 19. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Autism Treatment Market share, By Type, 2020 & 2027 (%)
10. Global Autism Treatment Market share, by Asperger Syndrome, By Type, 2015 - 2027 (USD Million)
11. Global Autism Treatment Market share, by Pervasive Developmental Disorder, By Type, 2015 - 2027 (USD Million)
12. Global Autism Treatment Market share, by Autistic Disorder, By Type, 2015 - 2027 (USD Million)
13. Global Autism Treatment Market share, by Disintegrative Disorder, By Type, 2015 - 2027 (USD Million)
14. Global Autism Treatment Market share, By Application, 2020 & 2027 (%)
15. Global Autism Treatment Market share, by Behavioral Approaches, By Application, 2015 - 2027 (USD Million)
16. Global Autism Treatment Market share, by Early Intervention, By Application 2015 - 2027 (USD Million)
17. Global Autism Treatment Market share, by Medication, By Application 2015 - 2027 (USD Million)
18. Global Autism Treatment Market share, by Dietary Approach, By Application 2015 - 2027 (USD Million)
19. Global Autism Treatment Market share, by Others, By Application 2015 - 2027 (USD Million)
20. Global Autism Treatment Market share, by region, 2020 & 2027 (%)
21. Global Autism Treatment Market share, by region, 2015 - 2027(USD Million)
22. North America Autism Treatment Market, 2015 - 2027(USD Million)
23. North America Autism Treatment Market share, by Countries, 2020 & 2027 (%)
24. U.S. Autism Treatment Market, 2015 - 2027(USD Million)
25. Canada Autism Treatment Market, 2015 - 2027(USD Million)
26. Mexico Autism Treatment Market, 2015 - 2027(USD Million)
27. Europe Autism Treatment Market, 2015 - 2027(USD Million)
28. Europe Autism Treatment Market share, by Countries, 2020 & 2027 (%)
29. Spain Autism Treatment Market, 2015 - 2027(USD Million)
30. UK Autism Treatment Market, 2015 - 2027(USD Million)
31. Italy Autism Treatment Market, 2015 - 2027(USD Million)
32. Germany Autism Treatment Market, 2015 - 2027(USD Million)
33. France Autism Treatment Market, 2015 - 2027(USD Million)
34. Rest of Europe Autism Treatment Market, 2015 - 2027(USD Million)
35. Asia-Pacific Autism Treatment Market, 2015 - 2027(USD Million)
36. Asia-Pacific Autism Treatment Market share, by Countries, 2020 & 2027 (%)
37. China Autism Treatment Market, 2015 - 2027(USD Million)
38. India Autism Treatment Market, 2015 - 2027(USD Million)
39. Australia Autism Treatment Market, 2015 - 2027(USD Million)
40. Japan Autism Treatment Market, 2015 - 2027(USD Million)
41. Rest of Asia-Pacific Autism Treatment Market, 2015 - 2027(USD Million)
42. Middle East & Africa Autism Treatment Market, 2015 - 2027(USD Million)
43. Middle East & Africa Autism Treatment Market share, by Countries, 2020 & 2027 (%)
44. GCC Autism Treatment Market, 2015 - 2027(USD Million)
45. South Africa Autism Treatment Market, 2015 - 2027(USD Million)
46. Rest Of Middle East & Africa Autism Treatment Market, 2015 - 2027(USD Million)
47. South America Autism Treatment Market, 2015 - 2027(USD Million)
48. Brazil Autism Treatment Market, 2015 - 2027(USD Million)
49. Mexico Autism Treatment Market, 2015 - 2027(USD Million)
50. Argentina Autism Treatment Market, 2015 - 2027(USD Million)
51. Rest Of South America Autism Treatment Market, 2015 - 2027(USD Million)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Autism Treatment Market, 2015-2027 (USD Million)
4. Autism Treatment requirement, by country, 2015-2027, (USD Million)
5. North America Autism Treatment Market, By Type, 2015-2027 (USD Million)
6. North America Autism Treatment Market, By Application, 2015-2027 (USD Million)
7. Europe Autism Treatment Market, By Type, 2015-2027 (USD Million)
8. Europe Autism Treatment Market, By Application, 2015-2027 (USD Million)
9. Asia Pacific Autism Treatment Market, By Type, 2015-2027 (USD Million)
10. Asia Pacific Autism Treatment Market, By Application, 2015-2027 (USD Million)
11. Middle East & Africa Autism Treatment Market, By Type, 2015-2027 (USD Million)
12. Middle East & Africa Autism Treatment Market, By Application, 2015-2027 (USD Million)
13. South America Autism Treatment Market, By Type, 2015-2027 (USD Million)
14. South America Autism Treatment Market, By Application, 2015-2027 (USD Million)
15. Global Autism Treatment Market, Company Market Share, 2020 - 2027 (%)
16. Bristol Myers Squibb: Product Benchmarking
17. Bristol Myers Squibb: Financial Performance
18. Otsuka Holdings Co.Ltd.: Product Benchmarking
19. Otsuka Holdings Co.Ltd.: Financial Performance
20. Novartis AG.: Product Benchmarking
21. Novartis AG.: Financial Performance
22. Roche Pharmaceuticals: Product Benchmarking
23. Roche Pharmaceuticals: Financial Performance
24. Janssen Pharmaceuticals: Product Benchmarking
25. Janssen Pharmaceuticals: Financial Performance
26. Pfizer Inc.: Product Benchmarking
27. Pfizer Inc.: Financial Performance
28. Actavis Inc.: Product Benchmarking
29. Actavis Inc.: Financial Performance
30. Autism Therapeutics: Product Benchmarking
31. Autism Therapeutics: Financial Performance
32. Teva Pharmaceuticals: Product Benchmarking
33. Teva Pharmaceuticals: Financial Performance
34. Q BioMed Inc.: Product Benchmarking
35. Q BioMed Inc.: Financial Performance
The Leading Key Players in Autism Treatment Market
